Guilford, CT
Summary
This business develops rapid molecular tests aimed at providing accurate and accessible diagnostics at the point of care. It focuses on creating solutions for sexual and family health, leveraging a unique molecular platform that delivers lab-quality results quickly and economically. The company has transitioned from developing at-home COVID-19 tests to a second-generation diagnostic platform for common infections, utilizing custom enzymes and AI-driven technology to enhance testing efficiency and accuracy.
8 of 8 checks passed
Label
Value
Active Dates
27.7 years — Since Apr 1997
Web Hosting
Platform
E-Mail Provider
Google GSuite
NAICS Code
621511
SIC 4 Digit Code
3841
SIC 2 Digit Code
38
Industry
1. Healthcare diagnostics
2. Medical Laboratories
Vendor
Source
Microsoft
TXT Record
Apple
TXT Record
Atlassian
TXT Record
Autodesk
TXT Record
DocuSign
TXT Record
Dropbox
TXT Record
TXT Record
Klaviyo
TXT Record
Miro
TXT Record
OpenAI
TXT Record
Shopify
TXT Record
Sophos
TXT Record
Stripe
TXT Record
ZenDesk
TXT Record
Workplace
TXT Record
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1997 |
|
|
|
|
|
|
|
|
|
|
|
|
1998 |
|
|
|
|
|
|
|
|
|
|
|
|
1999 |
|
|
|
|
|
|
|
|
|
|
|
|
2000 |
|
|
|
|
|
|
|
|
|
|
|
|
2001 |
|
|
|
|
|
|
|
|
|
|
|
|
2002 |
|
|
|
|
|
|
|
|
|
|
|
|
2003 |
|
|
|
|
|
|
|
|
|
|
|
|
2004 |
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
|
|
|
|
|
|
|
|
|
|
2011 |
|
|
|
|
|
|
|
|
|
|
|
|
2012 |
|
|
|
|
|
|
|
|
|
|
|
|
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
|
|
|
|
|
|
|
|
|
|
|
2018 |
|
|
|
|
|
|
|
|
|
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|